ID   ZDHC9_HUMAN             Reviewed;         364 AA.
AC   Q9Y397; B4F6G2; D3DTF9; Q59EK4; Q5JSW5; Q8WWS7; Q9BPY4; Q9NSP0; Q9NVL0;
AC   Q9NVR6;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2003, sequence version 2.
DT   28-JUN-2023, entry version 179.
DE   RecName: Full=Palmitoyltransferase ZDHHC9;
DE            EC=2.3.1.225 {ECO:0000269|PubMed:16000296};
DE   AltName: Full=Zinc finger DHHC domain-containing protein 9;
DE            Short=DHHC-9;
DE            Short=DHHC9;
DE   AltName: Full=Zinc finger protein 379;
DE   AltName: Full=Zinc finger protein 380;
GN   Name=ZDHHC9; Synonyms=CXorf11, ZDHHC10, ZNF379, ZNF380;
GN   ORFNames=CGI-89, UNQ261/PRO298;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=16193335; DOI=10.1007/s00262-005-0074-x;
RA   Zhou F.L., Zhang W.G., Chen G., Zhao W.H., Cao X.M., Chen Y.X., Tian W.,
RA   Liu J., Liu S.H.;
RT   "Serological identification and bioinformatics analysis of immunogenic
RT   antigens in multiple myeloma.";
RL   Cancer Immunol. Immunother. 55:910-917(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   INTERACTION WITH GOLGA7, AND MUTAGENESIS OF CYS-169.
RX   PubMed=16000296; DOI=10.1074/jbc.m504113200;
RA   Swarthout J.T., Lobo S., Farh L., Croke M.R., Greentree W.K.,
RA   Deschenes R.J., Linder M.E.;
RT   "DHHC9 and GCP16 constitute a human protein fatty acyltransferase with
RT   specificity for H- and N-Ras.";
RL   J. Biol. Chem. 280:31141-31148(2005).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27481942; DOI=10.1074/jbc.m116.725762;
RA   Adachi N., Hess D.T., McLaughlin P., Stamler J.S.;
RT   "S-Palmitoylation of a Novel Site in the beta2-Adrenergic Receptor
RT   Associated with a Novel Intracellular Itinerary.";
RL   J. Biol. Chem. 291:20232-20246(2016).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), SUBCELLULAR LOCATION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   "S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity.";
RL   Dev. Cell 56:1-18(2021).
RN   [13]
RP   VARIANTS MRXSR TRP-148 AND SER-150.
RX   PubMed=17436253; DOI=10.1086/513609;
RA   Raymond F.L., Tarpey P.S., Edkins S., Tofts C., O'Meara S., Teague J.,
RA   Butler A., Stevens C., Barthorpe S., Buck G., Cole J., Dicks E., Gray K.,
RA   Halliday K., Hills K., Hinton J., Jones D., Menzies A., Perry J., Raine K.,
RA   Shepherd R., Small A., Varian J., Widaa S., Mallya U., Moon J., Luo Y.,
RA   Shaw M., Boyle J., Kerr B., Turner G., Quarrell O., Cole T., Easton D.F.,
RA   Wooster R., Bobrow M., Schwartz C.E., Gecz J., Stratton M.R., Futreal P.A.;
RT   "Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and
RT   HRAS, cause X-linked mental retardation associated with a Marfanoid
RT   habitus.";
RL   Am. J. Hum. Genet. 80:982-987(2007).
RN   [14]
RP   VARIANTS MRXSR [LARGE SCALE ANALYSIS] TRP-148 AND SER-150.
RX   PubMed=19377476; DOI=10.1038/ng.367;
RA   Tarpey P.S., Smith R., Pleasance E., Whibley A., Edkins S., Hardy C.,
RA   O'Meara S., Latimer C., Dicks E., Menzies A., Stephens P., Blow M.,
RA   Greenman C., Xue Y., Tyler-Smith C., Thompson D., Gray K., Andrews J.,
RA   Barthorpe S., Buck G., Cole J., Dunmore R., Jones D., Maddison M.,
RA   Mironenko T., Turner R., Turrell K., Varian J., West S., Widaa S., Wray P.,
RA   Teague J., Butler A., Jenkinson A., Jia M., Richardson D., Shepherd R.,
RA   Wooster R., Tejada M.I., Martinez F., Carvill G., Goliath R.,
RA   de Brouwer A.P., van Bokhoven H., Van Esch H., Chelly J., Raynaud M.,
RA   Ropers H.H., Abidi F.E., Srivastava A.K., Cox J., Luo Y., Mallya U.,
RA   Moon J., Parnau J., Mohammed S., Tolmie J.L., Shoubridge C., Corbett M.,
RA   Gardner A., Haan E., Rujirabanjerd S., Shaw M., Vandeleur L., Fullston T.,
RA   Easton D.F., Boyle J., Partington M., Hackett A., Field M., Skinner C.,
RA   Stevenson R.E., Bobrow M., Turner G., Schwartz C.E., Gecz J., Raymond F.L.,
RA   Futreal P.A., Stratton M.R.;
RT   "A systematic, large-scale resequencing screen of X-chromosome coding exons
RT   in mental retardation.";
RL   Nat. Genet. 41:535-543(2009).
CC   -!- FUNCTION: Palmitoyltransferase that could catalyze the addition of
CC       palmitate onto various protein substrates (Probable). The ZDHHC9-GOLGA7
CC       complex is a palmitoyltransferase specific for HRAS and NRAS
CC       (PubMed:16000296). May have a palmitoyltransferase activity toward the
CC       beta-2 adrenergic receptor/ADRB2 and therefore regulate G protein-
CC       coupled receptor signaling (PubMed:27481942).
CC       {ECO:0000269|PubMed:16000296, ECO:0000269|PubMed:27481942}.
CC   -!- FUNCTION: (Microbial infection) Through a sequential action with
CC       ZDHHC20, rapidly and efficiently palmitoylates SARS coronavirus-2/SARS-
CC       CoV-2 spike protein following its synthesis in the endoplasmic
CC       reticulum (ER). In the infected cell, promotes spike biogenesis by
CC       protecting it from premature ER degradation, increases half-life and
CC       controls the lipid organization of its immediate membrane environment.
CC       Once the virus has formed, spike palmitoylation controls fusion with
CC       the target cell. {ECO:0000269|PubMed:34599882}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + L-cysteinyl-[protein] = CoA + S-
CC         hexadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:36683, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:11032, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74151;
CC         EC=2.3.1.225; Evidence={ECO:0000269|PubMed:16000296,
CC         ECO:0000269|PubMed:34599882};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36684;
CC         Evidence={ECO:0000305|PubMed:16000296};
CC   -!- SUBUNIT: Interacts with GOLGA7. {ECO:0000269|PubMed:16000296}.
CC   -!- INTERACTION:
CC       Q9Y397; O43889-2: CREB3; NbExp=3; IntAct=EBI-12690113, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16000296, ECO:0000269|PubMed:34599882}; Multi-pass
CC       membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:16000296, ECO:0000269|PubMed:27481942}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, skeletal muscle, brain,
CC       lung and liver. Absent in thymus, spleen and leukocytes.
CC       {ECO:0000269|PubMed:16000296}.
CC   -!- DOMAIN: The DHHC domain is required for palmitoyltransferase activity.
CC       {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked, syndromic,
CC       Raymond type (MRXSR) [MIM:300799]: A disorder characterized by
CC       significantly below average general intellectual functioning associated
CC       with impairments in adaptive behavior and manifested during the
CC       developmental period. Some MRXSR patients show additional features,
CC       including marfanoid habitus, epilepsy, facial dysmorphism, hypotonia,
CC       and behavioral problems. {ECO:0000269|PubMed:17436253,
CC       ECO:0000269|PubMed:19377476}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DHHC palmitoyltransferase family.
CC       ERF2/ZDHHC9 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34084.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA91683.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD93044.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB82308.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY952881; ACF60379.1; -; mRNA.
DR   EMBL; AF151847; AAD34084.1; ALT_INIT; mRNA.
DR   EMBL; AY358558; AAQ88922.1; -; mRNA.
DR   EMBL; AK001524; BAA91740.1; -; mRNA.
DR   EMBL; AK001424; BAA91683.1; ALT_INIT; mRNA.
DR   EMBL; AB209807; BAD93044.1; ALT_INIT; mRNA.
DR   EMBL; AL161962; CAB82308.1; ALT_INIT; mRNA.
DR   EMBL; AL034405; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471107; EAX11823.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11824.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11825.1; -; Genomic_DNA.
DR   EMBL; BC000035; AAH00035.1; -; mRNA.
DR   EMBL; BC003128; AAH03128.1; -; mRNA.
DR   EMBL; BC006200; AAH06200.1; -; mRNA.
DR   EMBL; BC012826; AAH12826.1; -; mRNA.
DR   CCDS; CCDS35395.1; -.
DR   RefSeq; NP_001008223.1; NM_001008222.2.
DR   RefSeq; NP_057116.2; NM_016032.3.
DR   AlphaFoldDB; Q9Y397; -.
DR   SMR; Q9Y397; -.
DR   BioGRID; 119302; 57.
DR   IntAct; Q9Y397; 22.
DR   STRING; 9606.ENSP00000349689; -.
DR   TCDB; 8.A.114.1.5; the huntington-interacting protein 14 (hip14) family.
DR   iPTMnet; Q9Y397; -.
DR   PhosphoSitePlus; Q9Y397; -.
DR   SwissPalm; Q9Y397; -.
DR   BioMuta; ZDHHC9; -.
DR   DMDM; 28202113; -.
DR   EPD; Q9Y397; -.
DR   jPOST; Q9Y397; -.
DR   MassIVE; Q9Y397; -.
DR   PaxDb; Q9Y397; -.
DR   PeptideAtlas; Q9Y397; -.
DR   ProteomicsDB; 85988; -.
DR   Antibodypedia; 30107; 254 antibodies from 32 providers.
DR   DNASU; 51114; -.
DR   Ensembl; ENST00000357166.11; ENSP00000349689.6; ENSG00000188706.13.
DR   Ensembl; ENST00000371064.7; ENSP00000360103.3; ENSG00000188706.13.
DR   GeneID; 51114; -.
DR   KEGG; hsa:51114; -.
DR   MANE-Select; ENST00000357166.11; ENSP00000349689.6; NM_016032.4; NP_057116.2.
DR   UCSC; uc004euv.4; human.
DR   AGR; HGNC:18475; -.
DR   CTD; 51114; -.
DR   DisGeNET; 51114; -.
DR   GeneCards; ZDHHC9; -.
DR   HGNC; HGNC:18475; ZDHHC9.
DR   HPA; ENSG00000188706; Low tissue specificity.
DR   MalaCards; ZDHHC9; -.
DR   MIM; 300646; gene.
DR   MIM; 300799; phenotype.
DR   neXtProt; NX_Q9Y397; -.
DR   OpenTargets; ENSG00000188706; -.
DR   Orphanet; 776; Lujan-Fryns syndrome.
DR   PharmGKB; PA38340; -.
DR   VEuPathDB; HostDB:ENSG00000188706; -.
DR   eggNOG; KOG1311; Eukaryota.
DR   GeneTree; ENSGT00940000159999; -.
DR   HOGENOM; CLU_018741_3_1_1; -.
DR   InParanoid; Q9Y397; -.
DR   OMA; YVTMFLI; -.
DR   OrthoDB; 5480099at2759; -.
DR   PhylomeDB; Q9Y397; -.
DR   TreeFam; TF312923; -.
DR   BRENDA; 2.3.1.225; 2681.
DR   PathwayCommons; Q9Y397; -.
DR   Reactome; R-HSA-9648002; RAS processing.
DR   Reactome; R-HSA-9694548; Maturation of spike protein.
DR   SignaLink; Q9Y397; -.
DR   SIGNOR; Q9Y397; -.
DR   BioGRID-ORCS; 51114; 13 hits in 779 CRISPR screens.
DR   ChiTaRS; ZDHHC9; human.
DR   GeneWiki; ZDHHC9; -.
DR   GenomeRNAi; 51114; -.
DR   Pharos; Q9Y397; Tbio.
DR   PRO; PR:Q9Y397; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q9Y397; protein.
DR   Bgee; ENSG00000188706; Expressed in corpus callosum and 173 other tissues.
DR   ExpressionAtlas; Q9Y397; baseline and differential.
DR   Genevisible; Q9Y397; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IC:UniProt.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0002178; C:palmitoyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016409; F:palmitoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IMP:UniProt.
DR   GO; GO:0043849; F:Ras palmitoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IDA:UniProtKB.
DR   GO; GO:0044794; P:positive regulation by host of viral process; IDA:UniProtKB.
DR   GO; GO:0018345; P:protein palmitoylation; IDA:UniProtKB.
DR   GO; GO:0006612; P:protein targeting to membrane; IBA:GO_Central.
DR   InterPro; IPR001594; Palmitoyltrfase_DHHC.
DR   PANTHER; PTHR22883:SF71; PALMITOYLTRANSFERASE ZDHHC9; 1.
DR   PANTHER; PTHR22883; ZINC FINGER DHHC DOMAIN CONTAINING PROTEIN; 1.
DR   Pfam; PF01529; DHHC; 1.
DR   PROSITE; PS50216; DHHC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Disease variant; Endoplasmic reticulum; Golgi apparatus;
KW   Host-virus interaction; Intellectual disability; Lipoprotein; Membrane;
KW   Palmitate; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..364
FT                   /note="Palmitoyltransferase ZDHHC9"
FT                   /id="PRO_0000212880"
FT   TOPO_DOM        1..35
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        36..56
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        57..63
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        64..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        85..183
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        184..204
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        205..228
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        229..249
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        250..364
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          139..189
FT                   /note="DHHC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00067"
FT   REGION          303..364
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        308..341
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        169
FT                   /note="S-palmitoyl cysteine intermediate"
FT                   /evidence="ECO:0000305|PubMed:16000296"
FT   VARIANT         148
FT                   /note="R -> W (in MRXSR; dbSNP:rs137852214)"
FT                   /evidence="ECO:0000269|PubMed:17436253,
FT                   ECO:0000269|PubMed:19377476"
FT                   /id="VAR_062674"
FT   VARIANT         150
FT                   /note="P -> S (in MRXSR; dbSNP:rs137852215)"
FT                   /evidence="ECO:0000269|PubMed:17436253,
FT                   ECO:0000269|PubMed:19377476"
FT                   /id="VAR_062675"
FT   MUTAGEN         169
FT                   /note="C->S: Abolishes palmitoyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:16000296"
FT   CONFLICT        35
FT                   /note="K -> R (in Ref. 4; BAA91740)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="F -> L (in Ref. 4; BAA91740)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        118..119
FT                   /note="QG -> GY (in Ref. 2; AAD34084)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   364 AA;  40916 MW;  D1E97F3A93CC439F CRC64;
     MSVMVVRKKV TRKWEKLPGR NTFCCDGRVM MARQKGIFYL TLFLILGTCT LFFAFECRYL
     AVQLSPAIPV FAAMLFLFSM ATLLRTSFSD PGVIPRALPD EAAFIEMEIE ATNGAVPQGQ
     RPPPRIKNFQ INNQIVKLKY CYTCKIFRPP RASHCSICDN CVERFDHHCP WVGNCVGKRN
     YRYFYLFILS LSLLTIYVFA FNIVYVALKS LKIGFLETLK ETPGTVLEVL ICFFTLWSVV
     GLTGFHTFLV ALNQTTNEDI KGSWTGKNRV QNPYSHGNIV KNCCEVLCGP LPPSVLDRRG
     ILPLEESGSR PPSTQETSSS LLPQSPAPTE HLNSNEMPED SSTPEEMPPP EPPEPPQEAA
     EAEK
//
